Opioid ligands are a class of G protein-coupled receptors known as opioid receptors. Dynorphins, enkephalins, endorphins, endomorphins, and nociceptin are examples of endogenous opioids. There are many opioid receptors in the brain, as well as in the spinal cord and digestive system. The body has molecules or sites called opioid receptors that are triggered by opioid substances. Opioid receptors prevent impulses from traveling along excitatory pathways in the human body.The serotonin, catecholamine, and substance P pathways are some of these pathways, and they are all thought to play a role in pain perception and feelings of wellbeing. Mu, delta, and kappa receptors are additional subclassifications of opioid receptors. While each class has its own unique way of acting, they all have some fundamental things in common. The potassium pump mechanism, which is present on the plasma membrane of most cells, powers them all.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
![β-Lipotropin (60-65) (β-LPH (60-65); [Arg0] Met-Enkephalin)](http://www.invivochem.com/upload/1124/V69919.png)
|
V69919 | β-Lipotropin (60-65) (β-LPH (60-65); [Arg0] Met-Enkephalin) | 60117-19-3 | β-Lipotropin (60-65) (β-LPH (60-65)) is an opioid peptide and a potent opioid agonist. |
|
V69942 | β-Lipotropin (61-69) (β-LPH (61-69)) | 59481-79-7 | β-Lipotropin (61-69) is a potent opioid agonist. |
|
V147781 | μ Opioid receptor agonist 4 | 6449-60-1 | μOpioid receptor agonist 4 is an agonist of the μOpioid receptor (MOP). |
|
V85004 | μ/κ/δ opioid receptor agonist 1 | ||
|
V85821 | σ1 Receptor/μ Opioid receptor modulator 2 | 3009018-61-2 | |
|
V19863 | Difelikefalin | 1024828-77-0 | Difelikefalin (MR-13A9; CR-845; MR-13A-9; trade name Korsuva) is a novel, peripherally specific, and potent kappa opioid receptor agonist approved in 2021 asan analgesic opiod peptide for the treatment of moderate-to-severe itching. |
|
V1274 | Nitrendipine (BAY-E-5009) | 39562-70-4 | Nitrendipine (BAY-E5009; BAY E-5009; Bayotensin; Bayotensin, Baypress, Nidrel, Deiten) is a potent dihydropyridine (DHP) calcium channel blocker (CCB) with antihypertensive effects. |
|
V29494 | Porcine dynorphin A(1-13) | 72957-38-1 | Porcine dynorphin A (1-13) is a potent endogenous κ opioid receptor agonist (activator) that relieves pain at physiological concentrations. |
|
V1281 | Trimebutine | 39133-31-8 | Trimebutine (Mebutin; Debridat; Polibutin; Modulon; Dromostat; Ibutin; Polibutin; TM 906; Trimedat)is a potent agonist of peripheral mu, kappa and delta(μ,κ, andδ)opioid receptors. |
|
V16816 | Trimebutine Maleate | 34140-59-5 | Trimebutine Maleate (also known as Mebutin)is a potent agonist of peripheral mu, kappa and delta opiate receptors, it is used as spasmolytic agent for treatment of both acute and chronic abdominal pain. |
|
V1277 | Lomerizine HCl (KB-2796) | 101477-54-7 | Lomerizine HCl (KB-2796; Migsis; KB2796; KB 2796), the dihydrochloride salt of Lomerizine, is a diphenylpiperazine-based, relatively new and potent L- and T-type CCB/calcium channel blocker used for the treatment of migraine. |
|
V1278 | Racecadotril (acetorphan) | 81110-73-8 | Racecadotril (also called acetorphan) is a potent and peripherally acting enkephalinase inhibitor used as an antidiarrheal medication. |
|
V6289 | Methylnaltrexone bromide | 73232-52-7 | Methylnaltrexone bromide is a novel and potent μ-opioid antagonist. |
|
V3722 | Alvimopan | 156053-89-3 | Alvimopan (also known as ADL 8-2698; LY 246736; HSDB-7704) is a novel peripheral micro opioid antagonist in clinical development for the management of post-operative ileus and opioid-induced bowel dysfunction. |
|
V3724 | Alvimopan dihydrate | 170098-38-1 | Alvimopan (also known as ADL 8-2698; LY 246736; HSDB-7704) is a novel peripheral micro opioid antagonist in clinical development for the management of post-operative ileus and opioid-induced bowel dysfunction. |
|
V3723 | Alvimopan monohydrate | 1383577-62-5 | Alvimopan (also known as ADL 8-2698; LY 246736; HSDB-7704) is a novel peripheral micro opioid antagonist in clinical development for the management of post-operative ileus and opioid-induced bowel dysfunction. |
|
V1273 | Loperamide HCl (R-18553) | 34552-83-5 | Loperamide HCl (R18553; ADL-2-1294; R-18553; ADL 2-1294; Imodium; Dissenten; Fortasec), the hydrochloride salt of loperamide, is a potent and selective μ-opioid receptor agonist used to reduce the frequency of diarrhea, also for IBD-inflammatory bowel disease and short bowel syndrome. |
|
V3777 | Naltrexone HCl | 16676-29-2 | Naltrexone HCl is a potentopioid receptor antagonist used mainly in the management of alcohol dependence and opioid dependence. |
|
V3775 | Naloxone HCl | 357-08-4 | Naloxone HCl is an inverse opioid agonist drug used to counteract the effects of opiate overdose. |
|
V1280 | Meptazinol HCl | 59263-76-2 | Meptazinol (IL-22811; WY-22811; IL22811; WY22811; trade name Meptid), the hydrochloride salt of meptazinol, is a centrally actiing opioid analgesic, which inhibits [3H]dihydromorphine binding with IC50 of 58 nM. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
